In the absence of federal action, states have attempted to rein in high pharmaceutical pricing by enacting laws aimed at regulating drug pricing. Following what now has become a trend, on March 13, 2018, Oregon became the newest state to enact such legislation, The Prescription Drug Price Transparency Act, H.B. 4005. But many of these
Latest Post
More Posts
FDA releases 2017 enforcement statistics and recall draft guidance
FDA relaxes FSMA enforcement
FDA commissioner discusses greater scrutiny of health claims on food packaging
FDA releases new guidances on increasing generic drug competition
Restaurant and convenience store trade groups sue NYC over menu labeling regulations
FDA extends compliance date for Nutrition Facts Label rule
FDA and NIH finalize clinical trial protocol template
FDA extends compliance date for menu labeling rule
Latest Executive Order shows support for agribusiness development and food safety
Subscribe: Subscribe via RSS
Blogs
Firm/Org